The Fort Worth Press - Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries

USD -
AED 3.672504
AFN 65.000368
ALL 81.216919
AMD 362.051328
ANG 1.789785
AOA 917.000367
ARS 1515.25437
AUD 1.435956
AWG 1.80125
AZN 1.70397
BAM 1.739803
BBD 2.01708
BDT 123.195303
BGN 1.747831
BHD 0.378775
BIF 2997.464751
BMD 1
BND 1.281146
BOB 11.69239
BRL 5.065104
BSD 1.001468
BTN 95.050483
BWP 13.720589
BYN 3.015879
BYR 19600
BZD 2.014233
CAD 1.41575
CDF 2313.50392
CHF 0.825932
CLF 0.024881
CLP 979.255437
CNY 6.691204
CNH 6.686704
COP 3173.953654
CRC 455.099408
CUC 1
CUP 24.035938
CVE 98.087444
CZK 21.645304
DJF 178.33919
DKK 6.651204
DOP 61.433083
DZD 133.824668
EGP 53.529689
ERN 15
ETB 163.585998
EUR 0.889904
FJD 2.26765
FKP 0.750199
GBP 0.752078
GEL 2.590391
GGP 0.750199
GHS 11.695058
GIP 0.750199
GMD 73.503851
GNF 8810.21216
GTQ 7.652004
GYD 209.527198
HKD 7.84815
HNL 26.885202
HRK 6.703804
HTG 131.147978
HUF 323.310388
IDR 18053
ILS 3.09465
IMP 0.750199
INR 94.965504
IQD 1518.213762
IRR 1795877.503816
ISK 121.180386
JEP 0.750199
JMD 159.195837
JOD 0.70904
JPY 158.01504
KES 130.098296
KGS 87.450384
KHR 4070.631144
KMF 440.00035
KPW 899.999961
KRW 1334.740383
KWD 0.31082
KYD 0.834586
KZT 453.195748
LAK 22534.359294
LBP 89683.40524
LKR 331.690611
LRD 170.751234
LSL 16.462394
LTL 2.95274
LVL 0.60489
LYD 6.431526
MAD 9.729662
MDL 17.966464
MGA 4507.405595
MKD 54.836988
MMK 2099.858992
MNT 3597.263832
MOP 8.096339
MRU 40.037362
MUR 47.230378
MVR 15.460378
MWK 1736.600987
MXN 18.492904
MYR 4.083204
MZN 63.903729
NAD 16.462394
NGN 1331.210377
NIO 36.854512
NOK 9.427704
NPR 152.081128
NZD 1.767253
OMR 0.382413
PAB 1.001468
PEN 3.444825
PGK 4.547436
PHP 62.986038
PKR 277.237468
PLN 3.88825
PYG 5719.877241
QAR 3.660721
RON 4.730604
RSD 104.461148
RUB 84.13468
RWF 1478.183516
SAR 3.752837
SBD 8.064647
SCR 13.905529
SDG 601.503676
SEK 9.912404
SGD 1.282104
SHP 0.754745
SLE 24.680371
SLL 20969.504398
SOS 572.343548
SRD 37.794504
STD 20697.981008
STN 21.794245
SVC 8.763065
SYP 13001.999685
SZL 16.455989
THB 33.445038
TJS 9.228751
TMT 3.51
TND 2.98768
TOP 2.40776
TRY 49.513804
TTD 6.798915
TWD 32.453604
TZS 2646.44398
UAH 44.920874
UGX 4136.458658
UYU 40.314905
UZS 12073.121914
VES 878.910604
VND 25894.5
VUV 119.757204
WST 2.787783
XAF 583.738825
XAG 0.017551
XAU 0.000240063761
XCD 2.70255
XCG 1.804919
XDR 0.707052
XOF 583.738825
XPF 106.089045
YER 236.150363
ZAR 16.494037
ZMK 9001.203584
ZMW 20.049815
ZWL 321.999592
SSP 5758.113256
MXV 2.088032
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries
Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries

Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries

Partnership combines AI-powered scientific and regulatory documentation with expert oversight to accelerate productivity and compliance across life sciences, defense, aerospace and energy

Text size:

ZURICH, SWITZERLAND / ACCESS Newswire / September 29, 2026 / Akkodis, a global leader in digital engineering consulting and part of the Adecco Group, and Biolevate, an AI-powered life sciences company, today announced a strategic partnership to accelerate AI-assisted scientific, regulatory and technical documentation in highly regulated industries. Initially launching in France and Belgium, with plans for expansion into additional markets, the partnership combines Biolevate's AI platform with Akkodis' engineering, validation and regulatory expertise to help organizations improve compliance, reduce documentation burdens and accelerate innovation.

In highly regulated industries, scientific, technical and compliance-related documentation is critical to product approvals, quality, patient safety and operational compliance. As documentation volumes increase, organizations continue to struggle with manual, resource-intensive processes that are difficult to scale. The result is a pressing need for AI-assisted documentation solutions that improve productivity while maintaining compliance, traceability and expert oversight.

The partnership between Akkodis and Biolevate addresses these challenges by combining AI-powered automation with domain expertise and governed workflows purpose-built for regulated environments. Biolevate reports scientific literature reviews can be completed up to 2.5 times faster, while clinical study report generation and regulatory dossier preparation times can be reduced by up to 50% and MedTech development workflows by up to 30%.

A complementary alliance of technology and expertise

Akkodis brings deep expertise in life sciences, validation engineering, quality systems, regulatory compliance and AI transformation. The company helps organizations implement, validate and scale technology-enabled processes in complex, compliance-driven environments, bridging the gap between emerging technologies and real-world operations.

Biolevate provides ELISE, an AI-powered knowledge and workflow platform for regulated environments. Using natural language processing, computer vision and graph-based AI models, the platform helps organizations accelerate scientific writing, regulatory documentation and knowledge management workflows. Designed around controlled sources, traceable evidence, expert review processes and governed workflows, ELISE enables organizations to apply AI in a more consistent, transparent and auditable manner. The platform also helps organizations operationalize institutional knowledge through reusable templates, predefined methodologies and standardized review processes, enabling more consistent execution of documentation workflows across teams.

Unlike conversational AI tools, ELISE is designed around controlled sources, traceable evidence and governed workflows required for regulated processes.

The joint offering combines Biolevate's AI-powered knowledge and workflow platform with Akkodis' consulting, engineering, quality, validation and regulatory expertise to help customers deploy and scale AI-enabled documentation processes. Together, the companies help organizations operationalize AI across high-stakes scientific, regulatory and compliance workflows while maintaining transparency, traceability and expert oversight.

Use cases delivered at scale

The partnership supports high-value workflows across regulated environments, including:

  • Scientific Writing - Systematic literature reviews (SLRs), clinical study reports (CSRs) and scientific documentation.
  • Regulatory Documentation and Medical Communications - Regulatory dossiers, submissions, medical communications and regulatory intelligence workflows.
  • Validation Engineering and Commissioning & Qualification (C&Q) - Validation documentation, compliance reviews and audit-readiness activities.
  • Medical Device Development - Product development workflows supporting regulatory readiness and lifecycle management.

"This partnership reflects the core of Akkodis Intelligence: combining advanced AI with deep human expertise to modernize scientific, regulatory and technical documentation," said Jo Debecker, President and CEO of Akkodis. "Organizations in highly regulated industries need more than powerful AI models. They need governed workflows that support expert decision-making. Together, Akkodis and Biolevate help clients operationalize AI in ways that are scalable, traceable and aligned with regulatory requirements."

"Biolevate's mission is to pave the way for faster therapies by bringing innovation where it's most needed," said Joël Belafa, Co-founder and CEO of Biolevate. "Partnering with Akkodis enables scientists, engineers, and regulatory teams to redefine how they work in the AI era, boosting productivity, safeguarding critical knowledge, and bringing high-quality solutions to market faster. It is a major milestone for us to address this challenge at a much larger scale and Akkodis is recognized for the quality of their experts and their strategic impact on every continent."

- End -

Media contacts

Anne Friedrich
SVP, Global Head of Communications, Akkodis
M. +4915174633470
E. [email protected]

Lisa Bushka
VP, External Communications, Akkodis
M. +18604630770
E. [email protected]

About Akkodis

Akkodis is a global digital engineering consulting company that enables organizations to innovate and accelerate by applying technology to redefine how processes and products are developed, powered and optimized. With deep expertise across AI, data, cloud, edge and software engineering, we offer best-in-class technology consultancy. Through our strong, scalable delivery models and specialized talent, we provide end-to-end solutions, from strategy and consulting through implementation. Our commitment to Akkodis Intelligence helps businesses connect the exponential power of technology with the irreplaceable strengths of human thinking and collaboration. Part of the Adecco Group and headquartered in Switzerland, Akkodis brings together 40,000 engineers and digital experts in over 30 countries, with services that span Consulting, Solutions and Academy. With deep experience across the world's major industries, Akkodis empowers businesses to solve complex challenges and achieve sustainable impact. akkodis.com | LinkedIn | Instagram | Facebook | X

About the Adecco Group

The Adecco Group is the world's leading talent company. Our purpose is making the future work for everyone. Through our three global business units - Adecco, Akkodis and LHH - across 60 countries, we enable sustainable and lifelong employability for individuals, deliver digital and engineering solutions to power transformation and empower organisations to optimise their workforces. The Adecco Group leads by example and is committed to an inclusive culture, fostering sustainable employability, and supporting resilient economies and communities. The Adecco Group AG is headquartered in Zurich, Switzerland (ISIN: CH0012138605) and listed on the SIX Swiss Exchange (ADEN). www.adeccogroup.com

About Biolevate

Biolevate is an AI-native technology company helping life sciences organizations turn complex scientific, operational and regulatory knowledge into reliable, repeatable workflows. Its platform processes documents and data across multiple formats, connects knowledge from diverse sources and coordinates specialized AI agents to support research, evidence reviews, scientific and regulatory writing, quality, manufacturing, safety and knowledge management. Biolevate enables organizations to use AI at scale with greater transparency, consistency and accountability, reducing manual work and accelerating critical processes from discovery to patients. The company supports organizations across the pharmaceutical value chain, including Sanofi and Merck/MSD, and is backed by leading investors including EQT Ventures and Orange Ventures.

www.biolevate.com | LinkedIn

SOURCE: Akkodis



View the original press release on ACCESS Newswire

T.M.Dan--TFWP